Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2007
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2646652A1 Substituted pyrazinone derivatives for use as a medicine
11/01/2007CA2644425A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
10/2007
10/31/2007EP1849785A1 N-(2-Thiazolyl)-amide derivatives as GSK-3 inhibitors
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849773A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative
10/31/2007EP1848715A1 Compounds having tie2 (tek) inhibitory activity
10/31/2007EP1848714A2 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
10/31/2007EP1848711A1 Fungicidal pyrazine derivatives
10/31/2007EP1848710A2 Heterocyclic substituted piperazines with cxcr3 antagonist activity
10/31/2007EP1848705A2 Exo- and diastereo- selective syntheses of himbacine analogs
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848694A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
10/31/2007EP1848435A2 Compounds for inflammation and immune-related uses
10/31/2007EP1848428A2 Thiazole amides, imidazole amides and related analogues
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1448551B1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
10/31/2007EP1448198B1 Nicotin-or isonicotin benzothiazole derivatives
10/31/2007EP1392665B1 Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1286998B2 Oxazolidinone derivatives with antibiotic activity
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007DE102005055355A1 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate 3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazine derivatives
10/31/2007DE102005055354A1 Substituierte 5-Phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazine Substituted 5-phenyl-3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazine
10/31/2007DE10134478B4 Verfahren zur Darstellung von thiazolsubstituierten β-Lactamen A process for the preparation of β-lactams thiazolsubstituierten
10/31/2007CN101065376A Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique
10/31/2007CN101065374A Substituted dipiperidine ccr2 antagonists
10/31/2007CN101065364A Novel pyrimidine derivatives and their use as PPAR-alpha modulators
10/31/2007CN101065363A Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
10/31/2007CN101062925A Paclitaxel derivatives, preparation method and medicinal composition and usage thereof
10/31/2007CN101062036A 5-(4-(2-n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same
10/31/2007CN100345846C Sodium sal ts of 5'-4'-2-(N-methyl-N-(2-pyridyl)amino) ethoxy [benzyl] thiazolidine-2,4-dione
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/30/2007US7288659 Acylaminothiazole derivatives, their preparation and therapeutic use
10/30/2007US7288547 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents
10/30/2007US7288544 Calcium channel antagonistic activity; especially useful as analgesics
10/30/2007US7288541 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
10/30/2007US7288537 Azetidine derivatives as CCR-3 receptor antagonists
10/30/2007CA2416212C Indole derivatives useful for the treatment of cns disorders
10/30/2007CA2239227C Nitrogen-containing heterocyclic compounds
10/30/2007CA2179650C Bisindolemaleimides and their use as protein kinase c inhibitors
10/25/2007WO2007121432A2 Benzoazepin-oxy-acetic acid derivatives as ppar-delta agonists used for the increase of hdl-c, lower ldl-c and lower cholesterol
10/25/2007WO2007120824A2 Processes for the synthesis of azetidinone
10/25/2007WO2007120574A2 Diaryl substituted alkanes
10/25/2007WO2007120096A1 Thiazol-guanidine derivatives useful as a (beta)- related pathologies
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119833A1 Nitrogen-containing heterocyclic compound
10/25/2007WO2007119600A1 Carbazole compound
10/25/2007WO2007119496A1 Tetomilast polymorphs
10/25/2007WO2007119461A1 Compound having thiadiazole ring structure substituted with pyridyl group and organic electroluminescent device
10/25/2007WO2007118900A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007WO2007118899A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007US20070249840 Process for the preparation of bis-benzazolyl compounds
10/25/2007US20070249833 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
10/25/2007US20070249708 C7 ester and c10 hydroxy substituted taxanes
10/25/2007US20070249701 Cyclic amine CCR5 receptor antagonists
10/25/2007US20070249691 Mercaptoimidazoles as Ccr2 Receptor Antagonists
10/25/2007US20070249645 Such as N-(3-Benzyloxy-phenyl)-N-(4-thiazol-2-yl-pyrimidin-2-yl)-amine; allergic diseases, cancer, neurodegenerative and proliferative disorders, diabetes; inhibitors of GSK-3, Aurora2, and Syk protein kinases
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249599 Novel Chemical Compounds
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070249586 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/25/2007US20070248594 Cxcr1 and cxcr2 chemokine antagonists
10/25/2007CA2725810A1 Tetomilast polymorphs
10/25/2007CA2725698A1 Tetomilast polymorphs
10/25/2007CA2725649A1 Tetomilast polymorphs
10/25/2007CA2649288A1 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling
10/25/2007CA2648892A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648891A1 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5ht6 receptor
10/25/2007CA2648748A1 Nitrogen-containing heterocyclic compound
10/25/2007CA2648555A1 Diaryl substituted alkanes
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1847534A2 Thiadiazoline derivative
10/24/2007EP1847532A1 Igf-1r inhibitor
10/24/2007EP1846400A2 Tricyclic delta-opioid modulators
10/24/2007EP1846388A1 Thiophene compounds for inflammation and immune-related uses
10/24/2007EP1846381A2 Novel heteroarylacetamides
10/24/2007EP1846379A1 Antidiabetic bicyclic compounds
10/24/2007EP1845991A2 Substituted 5-phenyl pyrimidines i in therapy
10/24/2007EP1218348B1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/24/2007EP1178983B1 Indole-type derivatives as inhibitors of p38 kinase
10/24/2007CN101061116A Sulfonamide compounds
10/24/2007CN101061115A 2-acylaminothiazole derivatives
10/24/2007CN101061114A Amide derivatives, their manufacture and use as pharmaceutical agents
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101061097A Novel gamma secretase inhibitors
10/24/2007CN101061096A Cycloalkyl keto piperidine tachykinin receptor antagonists
10/24/2007CN101061095A Cycloalkyl piperidine tachykinin receptor antagonists
10/24/2007CN101058574A Benzo [1,2,3] thiadiazoles derivatives, synthesis method and use thereof
10/24/2007CN101058573A 2-hydrazone substituted triazine compound, preparation method thereof, and medicinal composition and use using same as active component
10/24/2007CN100344627C Epothilones C, and its preparation and use as cell inhibitor
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism
10/23/2007US7285563 e.g. N-Benzyl-N'-isoquinolin-5-ylurea; treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1)
10/23/2007US7285562 Derivatives of 2-mercaptobenzothiazole, 2-mercaptobenzoxazole, 2-mercaptothiazolo[5,4-b]pyridine, or 2-mercaptooxazolo[5,4-b]pyridine; cardiovascular disorders, diabetes, cancer and obesity
10/23/2007US7285560 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases or atherosclerosis
10/23/2007US7285554 Pyrazole derivative
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 628